

274
National Health Profile 2018
6.3 (Contd.) Vaccinewise and Institution-wise status of production, demand and
supply 2015-16 & 2016-17.
10. Typhoid (Vi-Poly) - Installed Capcity, Production, Demand and Supply
Quantity in Lakh of Doses
S.
No
Institutions
Installed
Capacity
2015-16
2016-17
Status as on
Prodtn.
Demand supply % Achieved
Prodtn.
Demand supply % Achieved
1 Bio-Med (P) Ltd. Ghaziabad
120
14.8
13.7
13.7
100.00
14.8
13.7
13.7
100.00 March,2016
2 Zydus Aventis Ahmedabad
30
0
9
0
0.00
0
9
0
0.00 March,2014
3 BBI (L). Hy'bad
300
21
19.15
19.15
100.00
21
19.15
19.15
100.00 March,2014
4 Bharat Biotech Int.Ltd*
250
10
4.5
4.57
101.56
10
4.5
4.57
101.56 March, 2015
5 SanofiPasteurDelhi
4.06
4.54
4.54
100.00
4.06
4.54
4.54
100.00 March,2014
6 Bharat Biotech, Hy'd*
250
10
4.57
4.57
100.00
10
4.57
4.57
100.00 March,2015
Total
950
59.86
55.46
46.53
83.90
59.86
55.46
46.53
83.90
*
Newly added Institutions.
11. Typhoid (AKD) - Installed Capcity, Production, Demand and Supply
S.
No
Institutions
Installed
Capacity
2015-16
2016-17
Status as on
Prodtn.
Demand supply % Achieved
Prodtn.
Demand supply % Achieved
1 Bharat Biotecch Int.* Ltd
800
40
21.77
21.77
100.00
40
21.77
21.77
100.00 March,2015
2 Bio-Med Pvt. Ltd., Ghaziabad*
120
10.2
10.2
10.2
100.00
11.45
6.51
6.51
100.00 March,2017
Total
920
50.2
31.97
31.97
100.00
51.45
28.28
28.28
100.00
*
New Institution.
12. Hepatitis-B - Installed Capcity, Production, Demand and Supply*
S.
No
Institutions
Installed
Capacity
2015-16
2016-17
Status as on
Prodtn.
Demand supply % Achieved
Prodtn.
Demand supply % Achieved
1 SII Pune
2700
502
-
-
NA
806
NA
NA
NA March,2017
2 Panacea Bio-tech ltd. New Delhi-
multidose presentation
1670
-
-
-
NA
-
-
-
- March, 2013
2a Panacea Bio-tech Ltd. New Delhi-
single dose presentation
350
0
0
0
NA
0
0
0
- March, 2010
3 BBI (L), Hy'bad,
1000
2100
564.8
564.8
100.00
2100
564.8
564.8
100.00 March, 2011
4 HBI Udhagamandalam Hyderabad
400
164.3
-
157.8
NA
164.3
-
157.8
- March, 2016
5 Shanta bio technic Pvt. Ltd. Hy,bad
1200
213
588
546
92.86
213
588
546
92.86 March, 2013
6 Biological-E-Ltd.
1000
237.3
237.3
237.3
100.00
70
47.05
47.05
100.00 March, 2017
7 Bharat Biotech Int. Ltd*
1010
105
65.14
65.14
100.00
105
65.14
65.14
100.00 March, 2015
8 Sanofi Pasture India
8.3
8.58
8.58
100.00
8.3
8.58
8.58
100.00 March, 2013
Total
9330
3329.9 1463.82 1579.62
107.91
3466.6 1273.57 1389.37
109.09
*
New Institution.
13. Quaderivalent Meningococcal Minigitis Vaccine (QMMV) - Installed Capacity, Production, Demand and Supply
S.
No
Institutions
Installed
Capacity
2015-16
2016-17
Status as on
Prodtn.
Demand supply % Achieved
Prodtn.
Demand supply % Achieved
1 Bio-Med (P) Ltd. Ghaziabad
0.2
11.7
6.7
6.7
100.00
7.06
7.23
7.23
100.00 March, 2017
2 Sanofi Pasture India
NA
2.1
1.38
1.38
100.00
2.1
1.38
1.38
100.00 March, 2011
Total
0.2
13.8
8.08
8.08
100.00
9.16
8.61
8.61
100.00
14. Haemophilis (Hib) Influenzae vaccine - Installed Capacity, Production Demand and Supply
S.
No
Institutions
Installed
Capacity
2015-16
2016-17
Status as on
Prodtn.
Demand supply % Achieved
Prodtn.
Demand supply % Achieved
1 Bio-Med (P) Ltd. Ghaziabad
20
0.4
0.5
0.5
100.00
0.4
0.5
0.5
100.00 March, 2017
2 Biological E Ltd.Hyderabad
10
3.08
3.06
3.06
100.00
2
0.3
0.3
100.00 March,2017
3 Panacae
67.5
Nil
1.34
0.5
37.31
Nil
0.16
0.16
100.00 March,2017
4 Shanta Biotech. Ltd. H'bad
1000
-
-
-
-
-
-
-
- March, 2010
5 Sill Pune
1000
36
-
-
-
46
NA
NA
NA March,2017
6 Bharat Biotech
200
4
0.71
0.71
100.00
4
0.71
0.71
100.00 March, 2015
Total
2297.5
43.48
5.61
4.77
85.03
52.4
1.67
1.67
100.00